GSK To Buy BELLUS Health In US$2.0 Bln Deal
18/4 08:38
(RTTNews) - GSK plc (GSK, GSK.L) agreed to buy BELLUS Health Inc. (BLU, BLU.TO), a Canada-based, late-stage biopharmaceutical company working to better the lives of patients suffering from refractory chronic cough, for US$14.75 per share in cash representing an approximate total...